Survival advantage of upfront cytoreductive nephrectomy in patients with primary metastatic renal cell carcinoma compared with systemic and palliative treatments in a …
B Ljungberg, P Sundqvist, P Lindblad… - … journal of urology, 2020 - Taylor & Francis
Background Recently, the CARMENA and SURTIME studies, suggested that upfront
cytoreductive nephrectomy (CN) should be abandoned for patients with intermediate and …
cytoreductive nephrectomy (CN) should be abandoned for patients with intermediate and …
[PDF][PDF] Survival advantage of upfront cytoreductive nephrectomy in patients with primary metastatic renal cell carcinoma compared with systemic and palliative …
B Ljungberg, P Sundqvist, P Lindblad… - SCANDINAVIAN …, 2020 - academia.edu
Background: Recently, the CARMENA and SURTIME studies, suggested that upfront
cytoreductive nephrectomy (CN) should be abandoned for patients with intermediate and …
cytoreductive nephrectomy (CN) should be abandoned for patients with intermediate and …
[PDF][PDF] Survival advantage of upfront cytoreductive nephrectomy in patients with primary metastatic renal cell carcinoma compared with systemic and palliative …
B Ljungberg, P Sundqvist, P Lindblad… - SCANDINAVIAN …, 2020 - researchgate.net
Background: Recently, the CARMENA and SURTIME studies, suggested that upfront
cytoreductive nephrectomy (CN) should be abandoned for patients with intermediate and …
cytoreductive nephrectomy (CN) should be abandoned for patients with intermediate and …
Survival advantage of upfront cytoreductive nephrectomy in patients with primary metastatic renal cell carcinoma compared with systemic and palliative treatments in a …
B Ljungberg, P Sundqvist, P Lindblad… - … Journal of Urology …, 2020 - search.ebscohost.com
Recently, the CARMENA and SURTIME studies, suggested that upfront cytoreductive
nephrectomy (CN) should be abandoned for patients with intermediate and high-risk …
nephrectomy (CN) should be abandoned for patients with intermediate and high-risk …
Survival advantage of upfront cytoreductive nephrectomy in patients with primary metastatic renal cell carcinoma compared with systemic and palliative treatments in a …
B Ljungberg, P Sundqvist… - … Journal of Urology, 2020 - medicaljournalssweden.se
Background Recently, the CARMENA and SURTIME studies, suggested that upfront
cytoreductive nephrectomy (CN) should be abandoned for patients with intermediate and …
cytoreductive nephrectomy (CN) should be abandoned for patients with intermediate and …
Survival advantage of upfront cytoreductive nephrectomy in patients with primary metastatic renal cell carcinoma compared with systemic and palliative treatments in a …
B Ljungberg, P Sundqvist, P Lindblad… - … journal of urology, 2020 - diva-portal.org
Background: Recently, the CARMENA and SURTIME studies, suggested that upfront
cytoreductive nephrectomy (CN) should be abandoned for patients with intermediate and …
cytoreductive nephrectomy (CN) should be abandoned for patients with intermediate and …
Survival advantage of upfront cytoreductive nephrectomy in patients with primary metastatic renal cell carcinoma compared with systemic and palliative treatments in a …
B Ljungberg, P Sundqvist, P Lindblad… - … Journal of Urology, 2020 - europepmc.org
Background Recently, the CARMENA and SURTIME studies, suggested that upfront
cytoreductive nephrectomy (CN) should be abandoned for patients with intermediate and …
cytoreductive nephrectomy (CN) should be abandoned for patients with intermediate and …
Survival advantage of upfront cytoreductive nephrectomy in patients with primary metastatic renal cell carcinoma compared with systemic and palliative treatments in a …
B Ljungberg, P Sundqvist… - … journal of urology, 2020 - pubmed.ncbi.nlm.nih.gov
Background Recently, the CARMENA and SURTIME studies, suggested that upfront
cytoreductive nephrectomy (CN) should be abandoned for patients with intermediate and …
cytoreductive nephrectomy (CN) should be abandoned for patients with intermediate and …
[PDF][PDF] Survival advantage of upfront cytoreductive nephrectomy in patients with primary metastatic renal cell carcinoma compared with systemic and palliative …
B Ljungberg, P Sundqvist, P Lindblad… - SCANDINAVIAN …, 2020 - diva-portal.org
Background: Recently, the CARMENA and SURTIME studies, suggested that upfront
cytoreductive nephrectomy (CN) should be abandoned for patients with intermediate and …
cytoreductive nephrectomy (CN) should be abandoned for patients with intermediate and …